Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host...

Area of Science:

• Hematology
• Oncology
• Immunology

Background:

• Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous lymphoid malignancy with variable clinical outcomes.
• Transcriptional profiling has previously identified DLBCL subtypes linked to B-cell origin and patient prognosis.

Purpose of the Study:

• To identify robust and reproducible molecular subtypes of DLBCL using comprehensive transcriptional signatures.
• To investigate the role of the tumor microenvironment and host inflammatory response in DLBCL pathogenesis.

Main Methods:

• Analysis of a large series of newly diagnosed DLBCLs using whole genome arrays and multiple clustering techniques.
• Gene set enrichment analysis to characterize DLBCL subsets.
• Confirmation of identified subtypes in an independent patient cohort.

Main Results:

• Three distinct DLBCL subtypes were identified: "oxidative phosphorylation," "B-cell receptor/proliferation," and "host response" (HR).
• The HR subtype exhibited increased expression of immune-related genes, including T/NK cell receptors, complement components, and inflammatory mediators.
• HR DLBCLs showed significantly higher infiltration of specific immune cells, such as CD2+/CD3+ lymphocytes and S100+/GILT+ dendritic cells.
• The HR cluster shared characteristics with T-cell/histiocyte-rich B-cell lymphoma, including fewer genetic abnormalities and frequent organ involvement.

Conclusions:

• The tumor microenvironment and host inflammatory response are critical defining features of specific DLBCL subsets.
• The identification of the HR subtype suggests potential for targeted therapeutic strategies based on immune and inflammatory profiles in DLBCL.